Quince Therapeutics, Inc. (QNCX) — Long-term Investment Intensity
Quince Therapeutics, Inc. (QNCX) has a Long-term Investment Intensity of 0.1% as of September 2025. Long-term investments of $78.00K represent 0.1% of total assets of $109.90 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Quince Therapeutics, Inc. net assets for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Quince Therapeutics, Inc. Long-term Investment Intensity (2019–2024)
This chart shows how Quince Therapeutics, Inc.'s Long-term Investment Intensity has evolved across 6 annual periods from 2019 to 2024. As of September 2025, the intensity stands at 0.1%, reflecting long-term investments of $78.00K against total assets of $109.90 Million USD. Also explore Quince Therapeutics, Inc. assets under control for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Quince Therapeutics, Inc. (2019–2024)
The table below presents the year-by-year Long-term Investment Intensity for Quince Therapeutics, Inc. from 2019 to 2024, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Quince Therapeutics, Inc. market capitalisation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 0.1% | $78.00K | $114.48 Million | ▲ +0.0 pp |
| 2023 | 0.0% | $78.00K | $180.20 Million | ▼ -3.4 pp |
| 2022 | 3.4% | $3.58 Million | $103.91 Million | ▼ -11.5 pp |
| 2021 | 15.0% | $19.93 Million | $133.23 Million | ▼ -11.7 pp |
| 2020 | 26.6% | $50.46 Million | $189.47 Million | ▲ +13.2 pp |
| 2019 | 13.5% | $16.76 Million | $124.37 Million | — |